Jim Cramer says to buy FAANG stocks next time analysts say they’re not investable

Jim Cramer says to buy FAANG stocks next time analysts say they’re not investable


Investors should buy FAANG stocks next time they plunge and analysts turn bearish, CNBC’s Jim Cramer said Friday.

When analysts come out in droves to claim FAANG stocks are uninvestable, “that’ll be the perfect moment to do some buying,” he said. FAANG is Cramer’s acronym for Facebook-parent Meta, Amazon, Apple, Netflix and Google-parent Alphabet.

Cramer said that while analysts tend to praise big tech stocks during weeks like this one, when there’s little news about them reported, investors should beware of analysts turning the other way and churning out greatly exaggerated” reports of the stocks’ uninvestability when prices are down.

The “Mad Money” host also gave a rundown on recent developments from each of the FAANG companies, and gave his take on each stock.

Meta

Cramer said that CEO Mark Zuckerberg’s strategy of honing in on Reels to beat competitor TikTok, “that could be worth fifty points to the stock.”

Amazon

Cramer said that after looking at “the earnings power of their Web Services division and their advertising business,” he thinks the stock is “ridiculously undervalued.”

Apple

An Apple subscription service, which is reportedly launching later this year for iPhones, would allow them to “easily calculate the lifetime value of their subscribers, which would show Wall Street that the stock is worth a heck of a lot more than what we’re currently paying for it,” Cramer said.

Netflix

The company’s recent acquisition of Boss Fight Entertainment, its third gaming studio, shows that “Netflix promised a whole suite and that’s exactly what you’re getting,” Cramer said.

Alphabet

Google’s recently updated app store terms that offers third-party billing for app makers “means many content creators will sign up with Google quickly and make a ton of money,” Cramer said.

Disclosure: Cramer’s Charitable Trust owns shares of Alphabet, Amazon, Apple and Meta.

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer Twitter – Facebook – Instagram

Questions, comments, suggestions for the “Mad Money” website? [email protected]





Source

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals
Business

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals

Food and Drug Administration Commissioner Marty Makary warned that the U.S. is falling behind China in early-stage drug development and called for reforms that could streamline the process for starting trials on new treatments.  In an interview with CNBC on Wednesday, Makary specifically pointed to three bottlenecks that he said cause the U.S. to fall […]

Read More
Seattle Seahawks begin sale process after Super Bowl win
Business

Seattle Seahawks begin sale process after Super Bowl win

Dareke Young #83 of the Seattle Seahawks celebrates with teammates during the third quarter of the NFC Championship game against the Los Angeles Rams at Lumen Field on Jan. 25, 2026 in Seattle, Washington. Jane Gershovich | Getty Images The Seattle Seahawks are officially up for sale. The NFL team, which defeated the New England […]

Read More
FDA chief Marty Makary says ‘everything should be over the counter’ unless drug is unsafe or addictive
Business

FDA chief Marty Makary says ‘everything should be over the counter’ unless drug is unsafe or addictive

Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires monitoring – doubling down on a push that some in the pharmaceutical industry have questioned.  In an interview Wednesday in Washington, D.C., Makary said the FDA aims to make […]

Read More